Invention Application
- Patent Title: METHODS OF USING PD-L1 EXPRESSION IN TREATMENT DECISIONS FOR CANCER THERAPY
-
Application No.: US17729208Application Date: 2022-04-26
-
Publication No.: US20220252605A1Publication Date: 2022-08-11
- Inventor: Daniel ADAMS , Cha-Mei TANG
- Applicant: Creatv MicroTech, Inc.
- Applicant Address: US MD Potomac
- Assignee: Creatv MicroTech, Inc.
- Current Assignee: Creatv MicroTech, Inc.
- Current Assignee Address: US MD Potomac
- Main IPC: G01N33/574
- IPC: G01N33/574 ; A61K39/395 ; A61K45/06 ; C07K16/28
Abstract:
Methods of using detection of PD-L1 expression by circulating cancer cells in the screening, monitoring, treatment and diagnosis of cancer in subjects are disclosed. The methods are based on assaying one or more of circulating tumor cells (CTCs), epithelial to mesenchymal transition CTCs (EMTCTCs), cancer associated macrophage-like cells (CAMLs), and cancer associated vascular endothelial cells (CAVEs) isolated from a subject having cancer for PD-L1 expression.
Information query
IPC分类:
